⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3734453 | 0.57 | — | — | |
| SCHEMBL25099413 | 0.57 | — | — | |
| SCHEMBL14015993 | 0.56 | — | — | |
| SCHEMBL20762655 | 0.55 | — | — | |
| SCHEMBL20702295 | 0.54 | — | — | |
| SCHEMBL23462764 | 0.53 | — | — | |
| SCHEMBL2020974 | 0.51 | — | — | |
| SCHEMBL10425489 | 0.51 | — | — | |
| SCHEMBL12513370 | 0.51 | — | — | |
| SCHEMBL887146 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023107723-A2 | METHODS FOR TREATING NEUROLOGICAL DISORDERS | PROTHENA BIOSCIENCES LIMITED (IE) | 2023-06-15 | — | — | WO | disclosed |